妈富隆治疗青春期无排卵性子宫出血临床分析  

Clinical analysis of Mafulong in the treatment of anovulatory uterine bleeding during puberty

作　　者：杨家翠 Yang Jiacui(Department of Obstetrics and Gynecology,Nanjing High-tech Hospital,Jiangsu,Nanjing 211899,China)

机构地区：[1]南京市高新医院妇产科,江苏南京211899

出　　处：《实用妇科内分泌电子杂志》2021年第22期16-18,共3页Electronic Journal of Practical Gynecological Endocrinology

摘　　要：目的探讨妈富隆治疗青春期无排卵性子宫出血患者的临床疗效。方法选取80例青春期无排卵性子宫出血患者,以随机数字表法分为对照组(40例,补佳乐和黄体酮胶囊治疗)和研究组(40例,妈富隆治疗),所有患者均于止血后治疗三个周期,并于治疗后停药随访半年。比较两组临床疗效和并发症情况。结果治疗后,研究组临床总有效率为97.50%,高于对照组的80.00%,差异有统计学意义(P<0.05);治疗期间,两组并发症总发生率经比较,差异无统计学意义(P>0.05)。结论青春期无排卵性子宫出血采用妈富隆进行治疗,可提升临床治疗效果,且无较大不良反应,安全可靠。Objective To investigate the clinical effect of Maflong in the treatment of anovulatory uterine bleeding during puberty.Methods A total of 80 patients with adolescent anovulatory uterine bleeding were selected and randomly divided into the control group(40 cases,treated with Progesterone and Progesterone Capsules)and the research group(40 cases,treated with Maflong).All patients were treated for three cycles after hemostasis,and were followed up for half a year after treatment.The clinical efficacy and complications of the two groups were compared.Results After treatment,the total clinical effective rate in the research group was 97.50%,which was higher than 80.00%in the control group,and the difference was statistically significant(P<0.05).During the treatment,there was no significant difference in the total incidence of complications between the two groups(P>0.05).Conclusion Anovulatory uterine bleeding during puberty is treated with Maflong,which can improve the clinical treatment effect,and has no major adverse reactions,which is safe and reliable.

关 键 词：青春期子宫无排卵出血 妈富隆 临床疗效 不良反应 

分 类 号：R711.52[医药卫生—妇产科学]